Erratum: Sinks, suppressors and antigen presenters: How lymphodepletion enhances T cell-mediated tumor therapy: (Trends in Immunology (2005) 26 (111-117) DOI: 10.1016/j.it.2004.12.003);Sinks, suppressors and antigen presenters: How lymphodepletion enhances T cell-mediated tumor immunotherapy

Trends in Immunology

Volumn 26, Issue 2, 2005, Pages 111-117

  Klebanoff, Christopher A ^a,b   Khong, Hung T ^c   Antony, Paul A ^b   Palmer, Douglas C ^b   Restifo, Nicholas P ^b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF ALABAMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 15; INTERLEUKIN 21; INTERLEUKIN 7;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; APOPTOSIS; AUTOTRANSPLANTATION; CANCER IMMUNOTHERAPY; CANCER THERAPY; CELL ACTIVATION; CELL FUNCTION; HUMAN; IMMUNOCOMPETENT CELL; IN VIVO STUDY; LYMPHOCYTE DEPLETION; METASTASIS; NECROSIS; NONHUMAN; REVIEW; SOLID TUMOR; T LYMPHOCYTE; TREATMENT OUTCOME;

EID: 12744253307     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2005.04.006     Document Type: Erratum

References (85)

1. M.E. Dudley, and S.A. Rosenberg Adoptive-cell-transfer therapy for the treatment of patients with cancer Nat. Rev. Cancer 3 2003 666 675
2. S.A. Rosenberg Cancer immunotherapy: moving beyond current vaccines Nat. Med. 10 2004 909 915
3. M.A. Cheever Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2 J. Exp. Med. 155 1982 968 980
4. W.W. Overwijk gp100/pmel 17 is a murine tumor rejection antigen: induction of 'self'-reactive, tumoricidal T cells using high-affinity, altered peptide ligand J. Exp. Med. 188 1998 277 286
5. + T cells J. Exp. Med. 198 2003 569 580
6. + T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells Proc. Natl. Acad. Sci. U. S. A. 99 2002 16168 16173
7. M.E. Dudley Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes Science 298 2002 850 854
8. M.E. Dudley A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma J. Immunother. 25 2002 243 251
9. Z. Wu Homeostatic proliferation is a barrier to transplantation tolerance Nat. Med. 10 2004 87 92
10. B. Rocha, and H. von Boehmer Peripheral selection of the T cell repertoire Science 251 1991 1225 1228
11. E.B. Bell The stable and permanent expansion of functional T lymphocytes in athymic nude rats after a single injection of mature T cells J. Immunol. 139 1987 1379 1384
12. K. Murali-Krishna, and R. Ahmed Cutting edge: naïve T cells masquerading as memory cells J. Immunol. 165 2000 1733 1737
13. S. Oehen, and K. Brduscha-Riem Naïve cytotoxic T lymphocytes spontaneously acquire effector function in lymphocytopenic recipients: a pitfall for T cell memory studies? Eur. J. Immunol. 29 1999 608 614
14. A.W. Goldrath Naïve T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation J. Exp. Med. 192 2000 557 564
15. B.K. Cho Homeostasis-stimulated proliferation drives naïve T cells to differentiate directly into memory T cells J. Exp. Med. 192 2000 549 556
16. B. Ernst The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery Immunity 11 1999 173 181
17. C. King Homeostatic expansion of T cells during immune insufficiency generates autoimmunity Cell 117 2004 265 277
18. W. Dummer T cell homeostatic proliferation elicits effective antitumor autoimmunity J. Clin. Invest. 110 2002 185 192
19. G. Parmiani Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going? J. Natl. Cancer Inst. 94 2002 805 818
20. Z. Yu, and N.P. Restifo Cancer vaccines: progress reveals new complexities J. Clin. Invest. 110 2002 289 294
21. + T cells traffic indiscriminately and ubiquitously while mediating specific tumor destruction J. Immunol. 173 2004 7209 7216
22. W. Dummer Autologous regulation of naïve T cell homeostasis within the T cell compartment J. Immunol. 166 2001 2460 2468
23. A.W. Goldrath, and M.J. Bevan Selecting and maintaining a diverse T-cell repertoire Nature 402 1999 255 262
24. P.J. Morrissey Recombinant interleukin 7, pre-B cell growth factor, has costimulatory activity on purified mature T cells J. Exp. Med. 169 1989 707 716
25. J.D. Burton A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells Proc. Natl. Acad. Sci. U. S. A. 91 1994 4935 4939
26. K.H. Grabstein Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor Science 264 1994 965 968
27. + T cells J. Exp. Med. 195 2002 1533 1539
28. J. Marks-Konczalik IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice Proc. Natl. Acad. Sci. U. S. A. 97 2000 11445 11450
29. D.F. Tough Induction of bystander T cell proliferation by viruses and type I interferon in vivo Science 272 1996 1947 1950
30. + T cells in vivo by IL-15 Immunity 8 1998 591 599
31. D.F. Tough T cell stimulation in vivo by lipopolysaccharide (LPS) J. Exp. Med. 185 1997 2089 2094
32. L.A. Geiselhart IL-7 administration alters the CD4:CD8 ratio, increases T cell numbers, and increases T cell function in the absence of activation J. Immunol. 166 2001 3019 3027
33. K.L. Komschlies Administration of recombinant human IL-7 to mice alters the composition of B-lineage cells and T cell subsets, enhances T cell function, and induces regression of established metastases J. Immunol. 152 1994 5776 5784
34. T.J. Fry IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected non-human primates Blood 101 2003 2294 2299
35. T.J. Fry, and C.L. Mackall Interleukin-7: master regulator of peripheral T-cell homeostasis? Trends Immunol. 22 2001 564 571
36. K.S. Schluns Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo Nat. Immunol. 1 2000 426 432
37. + T cells J. Exp. Med. 195 2002 1515 1522
38. + cells J. Exp. Med. 195 2002 1523 1532
39. + T cells J. Exp. Med. 196 2002 935 946
40. T.C. Becker Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells J. Exp. Med. 195 2002 1541 1548
41. J.T. Tan IL-7 is critical for homeostatic proliferation and survival of naïve T cells Proc. Natl. Acad. Sci. U. S. A. 98 2001 8732 8737
42. S.M. Kaech Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells Nat. Immunol. 4 2003 1191 1198
43. + T cells Proc. Natl. Acad. Sci. U. S. A. 101 2004 1969 1974
44. G. Wang In vivo antitumor activity of interleukin 21 mediated by natural killer cells Cancer Res. 63 2003 9016 9022
45. K. Ozaki A critical role for IL-21 in regulating immunoglobulin production Science 298 2002 1630 1634
46. + T cell responses to achieve durable tumor immunity: comparative evaluation of IL-2, IL-15, and IL-21 J. Immunol. 173 2004 900 909
47. + regulatory T cells for immunologic self-tolerance and negative control of immune responses Annu. Rev. Immunol. 22 2004 531 562
48. + immunoregulatory T cells: central players in the arena of peripheral tolerance Semin. Immunol. 16 2004 81 88
49. T.R. Malek CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rβ-deficient mice. Implications for the nonredundant function of IL-2 Immunity 17 2002 167 178
50. + regulatory T cells Nat. Immunol. 4 2003 330 336
51. + regulatory T cell function J. Exp. Med. 196 2002 851 857
52. M. Asano Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation J. Exp. Med. 184 1996 387 396
53. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells J. Immunol. 160 1998 1212 1218
54. + regulatory T cells J. Immunol. 170 2003 3939 3943
55. + T lymphocytes Proc. Natl. Acad. Sci. U. S. A. 96 1999 2982 2987
56. W.W. Overwijk, and N.P. Restifo Autoimmunity and the immunotherapy of cancer: targeting the 'self' to destroy the 'other' Crit. Rev. Immunol. 20 2000 433 450
57. W.B. Bowne Coupling and uncoupling of tumor immunity and autoimmunity J. Exp. Med. 190 1999 1717 1722
58. G.Q. Phan Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma Proc. Natl. Acad. Sci. U. S. A. 100 2003 8372 8377
59. S.A. Rosenberg, and D.E. White Vitiligo in patients with melanoma: normal tissue antigens can be targets for cancer immunotherapy J. Immunother. Emphasis Tumor Immunol. 19 1996 81 84
60. + T cells: a common basis between tumor immunity and autoimmunity J. Immunol. 163 1999 5211 5218
61. U.K. Liyanage Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma J. Immunol. 169 2002 2756 2761
62. + T cells with IFN-γ-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination J. Immunol. 171 2003 5931 5939
63. + T cells Adv. Immunol. 81 2003 331 371
64. T.J. Curiel Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival Nat. Med. 10 2004 942 949
65. + regulatory T cells and their ligands: implications for immunotherapy Immunity 20 2004 107 118
66. + suppressor lymphocytes in the circulation of patients immunized against melanoma antigens J. Immunother. 26 2003 85 93
67. + T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer Cancer Res. 61 2001 4766 4772
68. E.Y. Woo Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation J. Immunol. 168 2002 4272 4276
69. T.J. Curiel Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival Nat. Med. 10 2004 942 949
70. A.D. Chernysheva T cell proliferation induced by autologous non-T cells is a response to apoptotic cells processed by dendritic cells J. Immunol. 169 2002 1241 1250
71. + cells following irradiation preconditioning and allogeneic spleen cell transplantation Bone Marrow Transplant. 33 2004 359 365
72. M.L. Sherman Regulation of tumor necrosis factor gene expression by ionizing radiation in human myeloid leukemia cells and peripheral blood monocytes J. Clin. Invest. 87 1991 1794 1797
73. C.Q. Xun Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice Blood 83 1994 2360 2367
74. + cells Blood 101 2003 2024 2032
75. H. Torihata Irradiation up-regulates CD80 expression through two different mechanisms in spleen B cells, B lymphoma cells, and dendritic cells Immunology 112 2004 219 227
76. + T cell-mediated acute graft-versus-host disease J. Clin. Invest. 109 2002 1335 1344
77. R.M. Kedl T cells compete for access to antigen-bearing antigen-presenting cells J. Exp. Med. 192 2000 1105 1113
78. H.C. Probst Cutting edge: competition for APC by CTLs of different specificities is not functionally important during induction of antiviral responses J. Immunol. 168 2002 5387 5391
79. G.R. Hill Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines Blood 90 1997 3204 3213
80. + T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells Nat. Immunol. 2 2001 415 422
81. M.J. van Stipdonk Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation Nat. Immunol. 2 2001 423 429
82. F. Mattei IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation J. Immunol. 167 2001 1179 1187
83. M.E. Dudley Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients J. Immunother. 26 2003 332 342
84. + T cell suppressor function J. Immunol. 172 2004 6519 6523
85. L. Zheng T cell growth cytokines cause the superinduction of molecules mediating antigen-induced T lymphocyte death J. Immunol. 160 1998 763 769